Antigens such as B7-H6, CD30, CD70, and CD276 (B7-H3) are highly expressed on tumor cells but are also found on normal cells, thereby increasing the risk of nontumor cell targeting. This evidence concerns the gene NCR3LG1 and neoplasm.